These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17609583)

  • 1. Identification of a key amino acid of the human 5-HT(2B) serotonin receptor important for sarpogrelate binding.
    Muntasir HA; Hossain M; Bhuiyan MA; Komiyama T; Nakamura T; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2007 Jul; 104(3):274-7. PubMed ID: 17609583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of amino acid residues important for sarpogrelate binding to the human 5-hydroxytryptamine2A serotonin receptor.
    Muntasir HA; Rashid M; Komiyama T; Kawakami J; Nagatomo T
    J Pharmacol Sci; 2006 Sep; 102(1):55-63. PubMed ID: 16974069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding.
    Muntasir HA; Takahashi J; Rashid M; Ahmed M; Komiyama T; Hossain M; Kawakami J; Nashimoto M; Nagatomo T
    Biol Pharm Bull; 2006 Aug; 29(8):1645-50. PubMed ID: 16880620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse agonist activity of sarpogrelate, a selective 5-HT2A-receptor antagonist, at the constitutively active human 5-HT2A receptor.
    Muntasir HA; Bhuiyan MA; Ishiguro M; Ozaki M; Nagatomo T
    J Pharmacol Sci; 2006 Oct; 102(2):189-95. PubMed ID: 17031071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of rat peripheral 5-HT(2A) and 5-HT(2B) receptor systems: influence of drug treatment.
    Enguix MJ; Sánchez L; Villazón M; Brea J; Tristán H; Caruncho HJ; Cadavid MI; Loza MI
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):79-90. PubMed ID: 12861437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of binding affinity to 5-hydroxytryptamine 2A (5-HT2A) receptor and inverse agonist activity of naftidrofuryl: comparison with those of sarpogrelate.
    Aly SA; Hossain M; Bhuiyan MA; Nakamura T; Nagatomo T
    J Pharmacol Sci; 2009 Aug; 110(4):445-50. PubMed ID: 19672037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
    Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding affinity of sarpogrelate, a new antiplatelet agent, and its metabolite for serotonin receptor subtypes.
    Nishio H; Inoue A; Nakata Y
    Arch Int Pharmacodyn Ther; 1996; 331(2):189-202. PubMed ID: 8937629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
    J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.
    Brea J; Rodrigo J; Carrieri A; Sanz F; Cadavid MI; Enguix MJ; Villazón M; Mengod G; Caro Y; Masaguer CF; Raviña E; Centeno NB; Carotti A; Loza MI
    J Med Chem; 2002 Jan; 45(1):54-71. PubMed ID: 11754579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT4 and 5-HT2 receptors antagonistically influence gap junctional coupling between rat auricular myocytes.
    Derangeon M; Bozon V; Defamie N; Peineau N; Bourmeyster N; Sarrouilhe D; Argibay JA; Hervé JC
    J Mol Cell Cardiol; 2010 Jan; 48(1):220-9. PubMed ID: 19615378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis.
    Manivet P; Schneider B; Smith JC; Choi DS; Maroteaux L; Kellermann O; Launay JM
    J Biol Chem; 2002 May; 277(19):17170-8. PubMed ID: 11859080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sarpogrelate, a novel 5-HT2 antagonist, on 5-HT-induced endothelium-dependent relaxations in porcine coronary artery.
    Rashid M; Nakazawa M; Nagatomo T
    Jpn J Pharmacol; 2002 Aug; 89(4):405-12. PubMed ID: 12233819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and functional affinity of sarpogrelate, its metabolite m-1 and ketanserin for human recombinant alpha-1-adrenoceptor subtypes.
    Israilova M; Suzuki F; Tanaka T; Nagatomo T; Taniguchi T; Muramatsu I
    Pharmacology; 2002 May; 65(2):69-73. PubMed ID: 11937776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified receptor internalization upon coexpression of 5-HT1B receptor and 5-HT2B receptors.
    Janoshazi A; Deraet M; Callebert J; Setola V; Guenther S; Saubamea B; Manivet P; Launay JM; Maroteaux L
    Mol Pharmacol; 2007 Jun; 71(6):1463-74. PubMed ID: 17325130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of the ligand binding site of the human 5-HT(4) receptor by site-directed mutagenesis and molecular modeling.
    Mialet J; Dahmoune Y; Lezoualc'h F; Berque-Bestel I; Eftekhari P; Hoebeke J; Sicsic S; Langlois M; Fischmeister R
    Br J Pharmacol; 2000 Jun; 130(3):527-38. PubMed ID: 10821780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.